Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Richards

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Gastroenterology|February 25, 2026
The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol UseFederica Tavaglione, Juan Vaz, Oveis Jamialahmadi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2020
Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference StandardVeeral H Ajmera, Edward R Cachay, Christian B Ramers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
Clinical utility of a 50% and 30% decline in MRI-PDFF in predicting fibrosis improvement in metabolic dysfunction-associated steatohepatitisRohit Loomba, Peter Chen-Yang Nikhil Daniel, Youxin Wang, et al.
Hepatology (Baltimore, Md.)|May 13, 2025
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsyRohit Loomba, Peter Chen-Yang Nikhil Daniel, Maral Amangurbanova, et al.
Gut|February 28, 2024
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASHRohit Loomba, Maral Amangurbanova, Ricki Bettencourt, et al.
Contemporary Clinical Trials|February 25, 2021
RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19Veeral Ajmera, Wesley K Thompson, Davey M Smith, et al.
Alimentary Pharmacology & Therapeutics|January 18, 2025
Head-to-Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective StudyFederica Tavaglione, Maral Amangurbanova, Alexander H Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2016
Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver DiseaseNiraj S Patel, Jonathan Hooker, Monica Gonzalez, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitisJanki Patel, Ricki Bettencourt, Jeffrey Cui, et al.
Journal of Hepatology|May 7, 2016
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trialJeffrey Cui, Len Philo, Phirum Nguyen, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Gastroenterology|February 25, 2026
The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol UseFederica Tavaglione, Juan Vaz, Oveis Jamialahmadi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2020
Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference StandardVeeral H Ajmera, Edward R Cachay, Christian B Ramers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
Clinical utility of a 50% and 30% decline in MRI-PDFF in predicting fibrosis improvement in metabolic dysfunction-associated steatohepatitisRohit Loomba, Peter Chen-Yang Nikhil Daniel, Youxin Wang, et al.
Hepatology (Baltimore, Md.)|May 13, 2025
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsyRohit Loomba, Peter Chen-Yang Nikhil Daniel, Maral Amangurbanova, et al.
Gut|February 28, 2024
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASHRohit Loomba, Maral Amangurbanova, Ricki Bettencourt, et al.
Contemporary Clinical Trials|February 25, 2021
RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19Veeral Ajmera, Wesley K Thompson, Davey M Smith, et al.
Alimentary Pharmacology & Therapeutics|January 18, 2025
Head-to-Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective StudyFederica Tavaglione, Maral Amangurbanova, Alexander H Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2016
Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver DiseaseNiraj S Patel, Jonathan Hooker, Monica Gonzalez, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitisJanki Patel, Ricki Bettencourt, Jeffrey Cui, et al.
Journal of Hepatology|May 7, 2016
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trialJeffrey Cui, Len Philo, Phirum Nguyen, et al.
Pageof 8